Abstract:
PURPOSE: A feed additive composition including novel lactobacillus species lactobacillus mixed bacterial strain is provided to offer the excellent antibacterial activity and starch resolution function for various pathogenic bacteria. CONSTITUTION: A feed additive composition contains a lactobacillus mixed bacterial strain formed with lactobacillus johnsonii G22-2, lactobacillus reuteri G8-5, and lactobacillus salivarius G1-1. The lactobacillus mixed bacterial strain has the antimicrobial activity against pathogenic bacteria, the starch degradation capability, the acid resistance, the bile tolerance, and the intestine adhesion capability.
Abstract:
PURPOSE: A feed additive composition containing Lactobacillus salivarius G1-1 is provided to ensure antibacterial activity to various pathogenic bacteria and to be used as a probiotic composition. CONSTITUTION: A Lactobacillus salivarius G1-1 is deposited in KACC91449P. The Lactobacillus salivarius G1-1 has 16s rDNA of sequence number 1 and is isolated from porcine small intestine by pure culture. A feed additive composition contains the Lactobacillus salivarius G1-1 as an active ingredient. The feed additive suppresses in vivo proliferation of pathogenic bacteria.
Abstract:
본 발명은 동물의 면역능을 증강시키는 더덕 추출물 및 그 제조방법과 용도에 관한 것이다. 보다 상세하게는 더덕줄기 및 잎을 음지에서 건조시켜 마쇄하여 열탕용 봉지에 넣고 증류수 중에 가열하여 1차 추출한 후, 추출물은 별도로 분리하고 잔류물에 재차 증류수를 넣고 열탕하여 2차 추출하여 추출물을 얻는 단계와, 1차 및 2차 추출물을 혼합하여 추출물에 2배량의 에탄올을 가하여 4∼6℃ 냉장실에서 24시간 정치시켜 침전된 다당체를 원심분리하는 단계와, 분리된 다당체를 순수 에탄올로 원심 세척한 후 35∼38℃ 항온실에서 건조하여 증류수로 1mg/ml 농도로 용해시켜 세균여과지로 여과하여 원액을 얻는 단계로 구성된다. 본 발명의 더덕추출물은 동물의 주요 면역세포인 호중구의 각종 활성과 싸이토카인 생성을 증강시키고 병원성세균의 공격접종에 대한 비특이적인 방어능을 증진시키는 효과가 있으므로 동물용 의약품으로써 면역증강제. 백신보좌제 첨가물 그리고 보조치료제 등으로 광범위하게 활용될 수 있을 것이다.
Abstract:
본 발명은 스트렙토마이세스 알부스 용균 추출물을 포함하는 백신 보좌제에 관한 것으로, 보다 자세히는 스트렙토마이세스 알부스(Streptomyces albus) 용균 추출물을 이용하여 동물의 면역 능력을 향상시키는 백신 보좌제에 관한 것으로, 동물의 주요 면역세포인 호중구 및 림프구 등의 활성을 증가시켜 병원성 세균의 공격에 대하여 면역 기능을 증진시키는 스트렙토마이세스 알부스(Streptomyces Albus) 용균 추출물을 포함하는 백신 보좌제를 제공하는 것을 목적으로 한다. 본 발명은 이와 같은 스트렙토마이세스 알부스로부터 추출한 용균 추출물을 이용하여 질병 방어에 주요한 역할을 담당하고 있는 각종 면역세포들의 기능을 증강시켜 질병 감염에 대한 특이 및 비특이적 저항성을 높여서, 질병으로부터 동물을 보호할 수 있는 효과를 제공한다. 스트렙토마이세스 알부스, 용균 추출물, 면역
Abstract:
A Glycyrrhiza hot water extract, a method for preparing the extract, and an immune enhance containing the extract are provided to improve the immune increasing activity of animals. A Glycyrrhiza hot water extract is prepared by adding 1,000 mL of distilled water per 100 g of the dried Glycyrrhiza to soak Glycyrrhiza for 20-30 min and boiling it down for 150 min to obtain an extract; adding 800 mL of distilled water per 100 g of the dried Glycyrrhiza to the Glycyrrhiza remaining after the extraction and boiling it down for 150 min to obtain an extract; adding 700 mL of distilled water per 100 g of the dried Glycyrrhiza to the Glycyrrhiza remaining after the extraction and boiling it down for 150 min to obtain an extract; collecting the obtained extract and concentrating it; and dry-freezing the concentrated one.
Abstract:
A preparation method of an inactivated vaccine of swine erysipelas containing an antigen treated with an inactivated swine complement against the antigen is provided to increase immunogenicity of the vaccine while safety of the vaccine is secured. The inactivated vaccine of swine erysipelas treated with an inactivated swine complement against antigen is prepared by adding the inactivated swine complement against antigen into the swine erysipelas antigen in a weight ratio of 1:10, and reacting the mixture at 37 deg.C for 1 hour, or by adding gel containing an immunostimulating agent as an adjuvant into the swine Erysipelas antigen in a weight ratio of 1:10.
Abstract:
본 발명은 바실러스 에스피 87 (KACC 91098) 및 이의 용도에 관한 것으로서, 상기 균주는 내산성, 내담즙성 및 생체 안전성이 인정되고, 병원성 세균 억제활성을 가지며, 장내에서 독립된 균총(Niche)으로서 미생물의 길항 작용을 통한 병원성 균총의 증식을 감소시켜 질병을 예방하는 효과가 있다.
Abstract:
PURPOSE: An antioxidant for supplementing feed using Forsythiae fructus extract and a preparation method for the Forsythiae Fructus extract are provided to show improved daily gain, feed intake, and feed efficiency compared to a control group. CONSTITUTION: An antioxidant for supplementing feed contains Forsythiae fructus extract. A method for preparing Forsythiae fructus extract comprises the following steps of: washing 100g Forsythiae fructus with water to remove dust; placing the washed Forsythiae fructus in a white bag; adding 1,000ml distilled water into the white bag to soak for 20-30 minutes; boiling down the soaked Forsythiae fructus for 150 minutes and obtaining an extract; adding another 800ml distilled water and boiling down for 150 minutes to obtain the extract; adding another 700ml distilled water and boiling down for 150 minutes to obtain the extract; collecting the extracts and concentrating until the volume becomes 100ml; and freeze-drying the concentrate.
Abstract:
A bacteriolysis extract of Saccharomyces chevalieri is provided to increase the activation of neutrophil and enhance non-specific defense activity against the pathogenic bacteria. An immune enhancer, vaccine adjuvant, adjuvant treating agent or feed additive comprises bacteriolysis extract of Saccharomyces chevalieri as an active ingredient. A method for manufacturing a bacteriolysis extract of Saccharomyces chevalieri comprises: a step of culturing Saccharomyces chevalieri in media at 26°C for 72 hours; a step of centrifuging media and suspending in PBS; a step of adding dissolution agent and treating at room temperature for 2-3 days; a step of confirming the dissolution status with a microscope; a step of adjusting pH concentration to 6.5-7.2; and a step of drying and maintaining in a refrigerator.
Abstract:
An immune enhancer and vaccine adjuvant additive for animal, which contains Zygosaccharomyces bailii lysates and an auxiliary therapeutic agent are provided to enhance the activation of neutrophil and non-specific protection effect to attack inoculation. An immune enhancer, vaccine adjuvant additive, auxiliary therapeutic agent and feed additive comprises a Zygosaccharomyces bailii lysates. A method for manufacturing the Zygosaccharomyces bailii lysate comprises: a step of culturing the Zygosaccharomyces bailii in the media at 26‹C for 72 hours; a step of centrifuging the cultured media and suspending in phosphate buffered saline (PBS); a step of adding dissolution agent and stirring at room temperature for two to three days; a step of adjusting pH concentration to 6.5-7.2; and a step of drying and maintaining in a thermostatic chamber.